Lability Landscape and Protease Resistance of Human Insulin Amyloid: A New Insight into Its Molecular Properties

Journal of Molecular Biology

Volumn 396, Issue 1, 2010, Pages 60-74

  Malisauskas, Mantas ^a   Weise, Christoph ^a   Yanamandra, Kiran ^a   Wolf Watz, Magnus ^a   Morozova Roche, Ludmilla ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

amyloid; atomic force microscopy; insulin; lability; seeding

Indexed keywords

AMYLOID; HUMAN INSULIN; THIOFLAVINE;

ANALYTIC METHOD; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOPHYSICS; CIRCULAR DICHROISM; ELECTROPHORESIS; GAS PHASE ELECTROPHORETIC MOBILITY MACROMOLECULE ANALYZER; GROWTH CURVE; HUMAN; IONIZATION; MACROMOLECULE; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LABILITY; PROTEIN STABILITY; PROTEIN STRUCTURE;

EID: 74649083540     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.11.012     Document Type: Article

References (62)

1. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
2. Ferreira S.T., Vieira M.N., and De Felice F.G. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59 (2007) 332-345
3. Yanamandra K., Alexeyev O., Zamotin V., Srivastava V., Shcukarev A., Brorsson A.C., et al. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS ONE 4 (2009) e5562
4. Tan S.Y., and Pepys M.B. Amyloidosis. Histopathology 25 (1994) 403-414
5. Westermark P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 272 (2005) 5942-5949
6. Harrison R.F., Hawkins P.N., Roche W.R., MacMahon R.F.T., Hubscher S.G., and Buckels J.A.C. 'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis. Gut 38 (1996) 151-152
7. Chamberlain A.K., MacPhee C.E., Zurdo J., Morozova-Roche L.A., Hill H.A., Dobson C.M., and Davis J.J. Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys. J. 79 (2000) 3282-3293
8. Morozova-Roche L.A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D.B., et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130 (2000) 339-351
9. Zhou W., Gallagher A., Hong D.P., Long C., Fink A.L., and Uversky V.N. At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to α-synuclein and prevents its fibrillation. J. Mol. Biol. 388 (2009) 597-610
10. Arnaudov L.N., and de Vries R. Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophys. J. 88 (2005) 515-526
11. De Felice F.G., Vieira M.N., Meirelles M.N., Morozova-Roche L.A., Dobson C.M., and Ferreira S.T. Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure. FASEB J. 18 (2004) 1099-1101
12. Sunde M., and Blake C.C.F. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50 (1997) 123-159
13. Makin O.S., and Serpell L.C. X-ray diffraction studies of amyloid structure. Methods Mol. Biol. 299 (2005) 67-80
14. Azriel R., and Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J. Biol. Chem. 276 (2001) 34156-34161
15. Smith J.F., Knowles T.P., Dobson C.M., Macphee C.E., and Welland M.E. Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl Acad. Sci. USA 103 (2006) 15806-15811
16. Takeda T., and Klimov D.K. Temperature-induced dissociation of Aβ monomers from amyloid fibril. Biophys. J. 95 (2008) 1758-1772
17. Meersman F., and Christopher M.D. Probing the pressure-temperature stability of amyloid fibrils provides new insights into their molecular properties. Biochim. Biophys. Acta 1764 (2006) 452-460
18. Yamamoto S., Hasegawa K., Yamaguchi I., Goto Y., Gejyo F., and Naiki H. Kinetic analysis of the polymerization and depolymerization of β(2)-microglobulin-related amyloid fibrils in vitro. Biochim. Biophys. Acta 1753 (2005) 34-43
19. Forloni G., Iussich S., Awan T., Colombo L., Angeretti N., Girola L., et al. Tetracyclines affect prion infectivity. Proc. Natl Acad. Sci. USA 99 (2002) 10849-10854
20. Gazit E. The "correctly folded" state of proteins: is it a metastable state?. Angew. Chem. 41 (2002) 257-259
21. Carulla N., Caddy G.L., Hall D.R., Zurdo J., Gairí M., Feliz M., et al. Molecular recycling within amyloid fibrils. Nature 436 (2005) 554-558
22. Paravastu A.K., Leapman R.D., Yau W.-M., and Tycko R. Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils. Proc. Natl Acad. Sci. USA 102 (2008) 18349-18354
23. Olofsson A., Lindhagen-Persson M., Sauer-Eriksson A.E., and Ohman A. Amide solvent protection analysis demonstrates that amyloid-β(1-40) and amyloid-β(1-42) form different fibrillar structures under identical conditions. Biochem. J. 404 (2007) 63-70
24. Shivaprasad S., and Wetzel R. Scanning cysteine mutagenesis analysis of Aβ-(1-40) amyloid fibrils. J. Biol. Chem. 281 (2006) 993-1000
25. Morozova-Roche L.A., Zamotin V., Malisauskas M., Ohman A., Chertkova R., Lavrikova M.A., et al. Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways. Biochemistry 43 (2004) 9610-9619
26. Malisauskas M., Zamotin V., Jass J., Noppe W., Dobson C.M., and Morozova-Roche L.A. Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration. J. Mol. Biol. 330 (2003) 879-890
27. Knowles T.P., Fitzpatrick A.W., Meehan S., Mott H.R., Vendruscolo M., Dobson C.M., and Welland M.E. Role of intermolecular forces in defining material properties of protein nanofibrils. Science 318 (2007) 1900-1903
28. Sun Y., Makarava N., Lee C.I., Laksanalamai P., Robb F.T., and Baskakov I.V. Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J. Mol. Biol. 376 (2008) 1155-1167
29. Harper J.D., and Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
30. Lundmark K., Westermark G.T., Olsen A., and Westermark P. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc. Natl Acad. Sci. USA 102 (2005) 6098-6102
31. Brange J. Towards understanding insulin fibrillation. J. Pharm. Sci. 86 (1997) 517-525
32. Ahmad A., Millett I.S., Doniach S., Uversky V., and Fink A.L. Partially folded intermediates in insulin fibrillation. Biochemistry 42 (2003) 11404-11416
33. Nettleton E.J., Tito P., Sunde M., Bouchard M., Dobson C.M., and Robinson C.V. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79 (2000) 1053-1065
34. Ahmad A., Millett I.S., Doniach S., Uversky V., and Fink A.L. Stimulation of insulin fibrillation by urea-induced intermediates. J. Biol. Chem. 279 (2004) 14999-15013
35. Brange J., Dodson G.G., Edwards D.J., Holden P.H., and Whittingham J.L. A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin). Proteins 27 (1997) 507-516
36. Dzwolak W., Loksztejn A., and Smirnovas V. New insights into the self-assembly of insulin amyloid fibrils: an H-D exchange FT-IR study. Biochemistry 45 (2006) 8143-8151
37. Loksztejn A., and Dzwolak W. Chiral bifurcation in aggregating insulin: an induced circular dichroism study. J. Mol. Biol. 379 (2008) 9-16
38. Nayak A., Sorci M., Krueger S., and Belfort G. A universal pathway for amyloid nucleus and precursor formation for insulin. Proteins 74 (2009) 556-565
39. Dzwolak W., Loksztejn A., Galinska-Rakoczy A., Adachi R., Goto Y., and Rupnicki L. Conformational indeterminism in protein misfolding: chiral amplification on amyloidogenic pathway of insulin. J. Am. Chem. Soc. 20 (2007) 7517-7522
40. Frokjaer S., and Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev., Drug Discov. 4 (2005) 298-306
41. Brange J., Hallund O., and Sørensen E. Chemical stability of insulin: 5. Isolation, characterization and identification of insulin transformation products. Acta Pharm. Nord. 4 (1992) 223-232
42. Brange J. The new era of biotech insulin analogues. Diabetalogia 40 (1997) S48-S53
43. Welsh G. Biopharmaceuticals: recent approvals and likely directions. Trends Biotechnol. 23 (2005) 553-558
44. Morozova-Roche L.A., and Malisauskas M.A. False paradise-mixed blessings in the protein universe: the amyloid as a new challenge in drug development. Curr. Med. Chem. 14 (2007) 1221-1230
45. Ratner R.E., Philips T.M., and Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 39 (1990) 728-733
46. Albert S.G., Obadiah J., Parseghian S.A., Yadira Hurley M., and Mooradian A.D. Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res. Clin. Pract. 75 (2007) 374-376
47. Dische F.E., Wernstedt C., Westermark G.T., Westermark P., Pepys M.B., Rennie J.A., et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 31 (1988) 158-161
48. Malisauskas M., Ostman J., Darinskas A., Zamotin V., Liutkevicius E., Lundgren E., and Morozova-Roche L.A. Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?. J. Biol. Chem. 280 (2005) 6269-6275
49. Malisauskas M., Meskys R., and Morozova-Roche L.A. Ultrathin silver nanowires produced by amyloid biotemplating. Biotechnol. Prog. 24 (2008) 1166-1170
50. Francois A., Maumus S., Vincent-Viry M., Gueguen R., Siest G., and Visvikis S. Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort. Clin. Chem. Lab. Med. 42 (2004) 1140-1149
51. Zamotin V., Gharibyan A., Gibanova N.V., Lavrikova M.A., Dolgikh D.A., Kirpichnikov M.P., et al. Cytotoxicity of albebetin oligomers depends on cross-β-sheet formation. FEBS Lett. 580 (2006) 2451-2457
52. Krebs M.R., Morozova-Roche L.A., Daniel K., Robinson C.V., and Dobson C.M. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci. 13 (2004) 1933-1938
53. Foderà V., Librizzi F., Groenning M., van de Weert M., and Leone M. Secondary nucleation and accessible surface in insulin amyloid fibril formation. J. Phys. Chem. B. 112 (2008) 3853-3858
54. Makarava N., Ostapchenko V.G., Savtchenko R., and Baskakov I.V. Conformational switching within individual amyloid fibrils. J. Biol. Chem. 284 (2009) 14386-14395
55. Foderà V., Cataldo S., Librizzi F., Pignataro B., Spiccia P., and Leone M. Self-organization pathways and spatial heterogeneity in insulin amyloid fibril formation. J. Phys. Chem. B. 113 (2009) 10830-10837
56. Jansen R., Dzwolak W., and Winter R. Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys. J. 88 (2005) 1344-1353
57. Librizzi F., and Rischel C. The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways. Protein Sci. 14 (2005) 3129-3134
58. Calamai M., Canale C., Telini A., Stefani M., Chiti F., and Dobson C.M. Reversal of protein aggregation provides evidence for multiple aggregated states. J. Mol. Biol. 346 (2005) 603-616
59. Polverino de Laureto P., Taddei N., Frare E., Capanni C., Costantini S., Zurdo J., et al. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J. Mol. Biol. 334 (2003) 129-141
60. Cabaleiro-Lago C., Quinlan-Pluck F., Lynch I., Lindman S., Minogue A.M., Thulin E., et al. Inhibition of amyloid β protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 130 (2008) 15437-15443
61. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
62. Foderà V., Groenning M., Vetri V., Librizzi F., Spagnolo S., Cornett C., et al. Thioflavin T hydroxylation at basic pH and its effect on amyloid fibril detection. J. Phys. Chem. B. 112 (2008) 15174-15181